《2011NICE2型糖尿病預(yù)防指南》內(nèi)容簡(jiǎn)介：

    This guidance represents the views of the Institute and was arrived at aftercareful consideration of the evidence available. Those working in the NHS,local authorities, the wider public, voluntary and community sectors and theprivate sector should take it into account when carrying out their professional,managerial or voluntary duties.

    《2011NICE2型糖尿病預(yù)防指南》內(nèi)容預(yù)覽：

    However, in January 2011 the World Health Organization （WHO）recommended that glycated haemoglobin （HbA1c） could be used as **ternative to standard glucose measures to diagnose type 2 diabetes amongnon-pregnant **s. HbA1clevels of 6.5% （48 mmol/mol） or above indicatethat someone has type 2 diabetes – but there is no fixed point to indicatewhen someone has 'pre-diabetes‘。 （Increasing levels of HbA1c,up to the 6.5%（48 mmol/mol） cut-off point, mean someone is at increasing risk of type 2diabetes.）

    The title of this guidance has been changed since it went out for consultationto reflect this move away from recognising 'pre-diabetes' as a separatecondition. However, the overall range and scope of the content remains thesame. The second piece of guidance will consider the effectiveness and costeffectiveness of interventions to prevent type 2 diabetes among individuals athigh-risk.

    點(diǎn)擊下載***：《2011NICE2型糖尿病預(yù)防指南》